Cargando…
Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest forms of cancer. A major reason for this situation is the fact that these tumors are already resistant or become rapidly resistant to all conventional therapies. Like any transformation process, initiation and development of PDCA are dr...
Autores principales: | Swayden, Mirna, Iovanna, Juan, Soubeyran, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299038/ https://www.ncbi.nlm.nih.gov/pubmed/30582059 http://dx.doi.org/10.1016/j.heliyon.2018.e01055 |
Ejemplares similares
-
Upcoming Revolutionary Paths in Preclinical Modeling of Pancreatic Adenocarcinoma
por: Swayden, Mirna, et al.
Publicado: (2020) -
Chloroquine plays a cell-dependent role in the response to treatment of pancreatic adenocarcinoma
por: Molejon, María Inés, et al.
Publicado: (2018) -
Can the plasma PD-1 levels predict the presence and efficiency of tumor-infiltrating lymphocytes in patients with metastatic melanoma?
por: Incorvaia, Lorena, et al.
Publicado: (2019) -
MiR-93 is related to poor prognosis in pancreatic cancer and promotes tumor progression by targeting microtubule dynamics
por: Vila-Navarro, Elena, et al.
Publicado: (2020) -
Tolerant/Persister Cancer Cells and the Path to Resistance to Targeted Therapy
por: Swayden, Mirna, et al.
Publicado: (2020)